Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir diphosphate in seminal cells and semen quality with TAF/FTC/EVG/COBI in HIV-1 infected men
2016-001371-69Phase 4Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tenofovir alafenamide in human immunodeficiency virus infection (HIV), sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoint: TFV-DP concentration in seminal mononuclear cells at week 12. Started Aug 2016; status: completed.
02
Drugs
tenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2016-001371-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001371-69.